160 related articles for article (PubMed ID: 1374944)
1. Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
Demetris AJ; Fung JJ; Todo S; McCauley J; Jain A; Takaya S; Alessiani M; Abu-Elmagd K; Van Thiel DH; Starzl TE
Transplantation; 1992 May; 53(5):1056-62. PubMed ID: 1374944
[TBL] [Abstract][Full Text] [Related]
2. FK506 conversion therapy in pediatric liver transplantation.
Egawa H; Esquivel CO; So SK; Cox K; Concepcion W; Lawrence L
Transplantation; 1994 Apr; 57(8):1169-73. PubMed ID: 7513911
[TBL] [Abstract][Full Text] [Related]
3. The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
McDiarmid SV; Wallace P; Vargas J; Ament ME; Busuttil RW
J Pediatr Gastroenterol Nutr; 1995 Apr; 20(3):291-9. PubMed ID: 7541834
[TBL] [Abstract][Full Text] [Related]
4. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Cao S; Cox KL; Berquist W; Hayashi M; Concepcion W; Hammes GB; Ojogho OK; So SK; Frerker M; Castillo RO; Monge H; Esquivel CO
Pediatr Transplant; 1999 Feb; 3(1):22-6. PubMed ID: 10359027
[TBL] [Abstract][Full Text] [Related]
6. Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children.
Reding R; Wallemacq PE; Lamy ME; Rahier J; Sempoux C; Debande B; Jamart J; Barker A; Sokal E; De Ville de Goyet J
Transplantation; 1994 Jan; 57(1):93-100. PubMed ID: 7507272
[TBL] [Abstract][Full Text] [Related]
7. FK506 conversion for intractable rejection of the liver allograft.
McDiarmid SV; Klintmalm GB; Busuttil RW
Transpl Int; 1993; 6(6):305-12. PubMed ID: 7507675
[TBL] [Abstract][Full Text] [Related]
8. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
[TBL] [Abstract][Full Text] [Related]
9. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
[TBL] [Abstract][Full Text] [Related]
10. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P
J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
12. FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations.
Hytiroglou P; Lee R; Sharma K; Theise ND; Schwartz M; Miller C; Thung SN
Transplantation; 1993 Dec; 56(6):1389-94. PubMed ID: 7506452
[TBL] [Abstract][Full Text] [Related]
13. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
[TBL] [Abstract][Full Text] [Related]
14. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience.
Selzner N; Durand F; Bernuau J; Heneghan MA; Tuttle-Newhall JE; Belghiti J; Clavien PA
Transplantation; 2001 Sep; 72(6):1061-5. PubMed ID: 11579301
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
[TBL] [Abstract][Full Text] [Related]
16. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.
Wiesner RH
Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494
[TBL] [Abstract][Full Text] [Related]
17. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
[TBL] [Abstract][Full Text] [Related]
18. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
Raofi V; Holman DM; Coady N; Vazquez E; Dunn TB; Bartholomew AM; Pollak R; Benedetti E
Am J Surg; 1999 Apr; 177(4):299-302. PubMed ID: 10326847
[TBL] [Abstract][Full Text] [Related]
20. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
